DOI: 10.1055/s-00000007

Aktuelle Urologie

References

Escudier B, Sharma P, McDermott DF. et al.
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma.

Eur Urol 2017;
72: 962-971

Download Bibliographical Data

Search in:
Access: